Amplo Biotechnology Secures Fast Track STTR Funding for AMP-201, a Promising Gene Therapy Targeting Collagen Q Deficiency ...Middle East

SAN DIEGO, May 29, 2023 /PRNewswire/ -- Amplo Biotechnology, a leading US-based biotech company dedicated to developing innovative AAV-based gene therapies for neuromuscular junction disorders announced the award of a Fast Track Phase I/II STTR grant from the NIH-NINDS. This highly...

Hence then, the article about amplo biotechnology secures fast track sttr funding for amp 201 a promising gene therapy targeting collagen q deficiency was published today ( Wednesday 31/05/2023 - 11:29 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Amplo Biotechnology Secures Fast Track STTR Funding for AMP-201, a Promising Gene Therapy Targeting Collagen Q Deficiency )

Also on site :

• My Daughter’s Friend Has a Crush on My Husband. It’s Making Us Both Deeply Uncomfortable.
• Maga’s biggest fear is coming true and Trump won’t survive it
• Governor Hochul: Annual statewide donation drive is complete